How do I buy CASI Pharmaceuticals (CASI) stock?

You can purchase shares of CASI Pharmaceuticals (NASDAQ:CASI) through any online brokerage.View our list of the best stock brokerages

Who are CASI Pharmaceuticals (CASI) competitors?

Other companies in CASI Pharmaceuticals’s space includes: Cellectar Biosciences Inc (NASDAQ:CLRB), Imunon Inc (NASDAQ:IMNN), Sensei Biotherapeutics Inc (NASDAQ:SNSE), AIxCrypto Holdings Inc (NASDAQ:AIXC) and Lisata Therapeutics Inc (NASDAQ:LSTA).

What is the forecast, or price target, for CASI Pharmaceuticals (CASI) stock?

CASI Pharmaceuticals has a consensus price target of $4.00.

What is the current price for CASI Pharmaceuticals (CASI)?

The stock price for CASI Pharmaceuticals (NASDAQ: CASI) is $0.9616 last updated January 14, 2026 at 11:48 AM EST.

Does CASI Pharmaceuticals (CASI) pay a dividend?

There are no upcoming dividends for CASI Pharmaceuticals.

When is CASI Pharmaceuticals (NASDAQ:CASI) reporting earnings?

CASI Pharmaceuticals does not have any upcoming earnings scheduled.

Is CASI Pharmaceuticals (CASI) going to split?

There is no upcoming split for CASI Pharmaceuticals.

What sector and industry does CASI Pharmaceuticals (CASI) operate in?

CASI Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

CASI Pharmaceuticals (CASI) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Biotechnology

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is us...

Comments